Abstract
ObjectivesTo determine the proportion of patients with psoriatic arthritis in the Adalimumab Effectiveness in Psoriatic Arthritis trial achieving minimal disease activity (MDA) and its individual components at 1 or more...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have